iifl-logo

Hindustan Unilever Ltd Quarterly Results

2,553.7
(1.29%)
Aug 1, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Jun-2025Mar-2025Dec-2024Sept-2024Jun-2024

Gross Sales

16,323

15,446

15,590

15,729

15,523

Excise Duty

0

0

0

0

0

Net Sales

16,323

15,446

15,590

15,729

15,523

Other Operating Income

191

224

228

197

184

Other Income

201

309

740

219

257

Total Income

16,715

15,979

16,558

16,145

15,964

Total Expenditure

12,924

12,190

12,123

12,155

12,013

PBIDT

3,791

3,789

4,435

3,990

3,951

Interest

127

80

112

110

93

PBDT

3,664

3,709

4,323

3,880

3,858

Depreciation

361

347

341

338

329

Minority Interest Before NP

0

0

0

0

0

Tax

494

849

978

940

853

Deferred Tax

41

38

15

7

64

Reported Profit After Tax

2,768

2,475

2,989

2,595

2,612

Minority Interest After NP

12

11

5

4

2

Net Profit after Minority Interest

2,756

2,464

2,984

2,591

2,610

Extra-ordinary Items

-106.43

-101.59

380.57

-11.72

-35.53

Adjusted Profit After Extra-ordinary item

2,862.43

2,565.59

2,603.43

2,602.72

2,645.53

EPS (Unit Curr.)

11.73

10.48

12.7

11.03

11.11

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

2,900

0

Equity

235

235

235

235

235

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

23.22

24.53

28.44

25.36

25.45

PBDTM(%)

22.44

24.01

27.72

24.66

24.85

PATM(%)

16.95

16.02

19.17

16.49

16.82

Hind. Unilever: Related NEWS

HUL Cuts Prices of Key FMCG Products, But Skincare Gets Costlier
1 Aug 2025|02:25 PM

In addition to softer raw material costs, intensified competition in the FMCG space has played a role in prompting this pricing adjustment.

Read More
HUL Q1 Updates: PAT jumps 8% y-o-y to ₹2,732 Crore
31 Jul 2025|12:44 PM

On the other hand, EBITDA for the quarter stood at ₹3,718 Crore. This was marginally down against ₹3,744 Crore in the previous corresponding period.

Read More
Top Stocks for Today - 11th July 2025
11 Jul 2025|07:20 AM

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

Read More
HUL Q4 Net Profit Rises to ₹2,493 Crore
25 Apr 2025|10:59 PM

HUL registered EBITDA of ₹3,466 crore in the March quarter, a 1% year-on-year increase. EBITDA margin for the quarter was 22.8%.

Read More
Top Stocks for Today - 22nd April 2025
22 Apr 2025|07:31 AM

Here are some of the stocks that may see significant price movement today: Brigade Enterprises, Coal India, Hindustan Unilever, etc.

Read More
HUL names Rajneet Kohli as executive director of foods business
27 Mar 2025|09:04 AM

As per the company, Kohli will take up the position on April 7, 2025, succeeding Shiva Krishnamurthy. He is leaving to pursue other opportunities.

Read More
Top Stocks for Today - 23rd January 2025
23 Jan 2025|07:09 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, BPCL, Persistent Systems, etc.

Read More
HUL Bypasses Distributors, Targets Kiranas Directly
31 Dec 2024|01:11 PM

Nearly 80% of FMCG sales in India are controlled by kirana stores, which are supplied by distributors or wholesalers.

Read More
Top Stocks for Today - 3rd December 2024
3 Dec 2024|07:22 AM

Here are some of the stocks that may see significant price movement today: Torrent Pharma, Hindustan Unilever, Nazara Tech, etc.

Read More
HUL Pays ₹192.55 Crore in Tax Demand Dispute
2 Dec 2024|08:19 PM

The dispute stems from an issue surrounding tax deduction at source (TDS) for a ₹3,045-crore payment HUL made to acquire intellectual property rights related to its India HFD business from GlaxoSmithKline (GSK).

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.